setanaxib   Click here for help

GtoPdb Ligand ID: 9932

Synonyms: GKT-137831 | GKT-831 | GKT137831 | GKT831 [3]
Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: Setanaxib (GKT137831) is an investigational dual NOX1/NOX4 inhibitor [1]. It has shown anti-inflammatory activity in models of liver fibrosis [1] and retinopathy [2].
Click here for help

Ligand Activity Visualisation Charts

These are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts.

✖

View interactive charts of activity data across species
2D Structure
Click here for help

2D Structure

An image of the ligand's 2D structure. For small molecules with SMILES these are drawn using the NCI/CADD Chemical Identifier Resolver. Click on the image to access the chemical structure search tool with the ligand pre-loaded in the structure editor. For other types of ligands, e.g. longer nucleotides and peptides, a manually drawn representation of the molecule may be provided.

✖
Click here for structure editor
Physico-chemical Properties
Click here for help

Physico-chemical Properties

Calculated molecular properties are available for small molecules and natural products (not peptides). Properties were generated using the CDK toolkit. All properties were selected to enable the prediction of the Lipinski Rule-of-Five profile or ‘druglikeness’ for each ligand. For more info on each category see the help pages.

✖
Hydrogen bond acceptors 3
Hydrogen bond donors 1
Rotatable bonds 3
Topological polar surface area 62.51
Molecular weight 394.12
XLogP 5.42
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help

SMILES / InChI / InChIKey

SMILES (Simplified Molecular Input Line Entry Specification) A specification for unambiguously describing the structure of chemical molecules using short ASCII strings. Canonical SMILES specify a unique representation of the 2D structure without chiral or isotopic specifications. Isomeric SMILES include chiral specification and isotopes.

Standard InChI (IUPAC International Chemical Identifier) and InChIKey InChI is a non-proprietary, standard, textual identifier for chemical substances designed to facilitate linking of information and database searching. An InChIKey is a simplified version of a full InChI, designed for easier web searching.

✖
Canonical SMILES Clc1ccccc1n1[nH]c2c(c1=O)c(c1cccc(c1)N(C)C)n(c(=O)c2)C
Isomeric SMILES Clc1ccccc1n1[nH]c2c(c1=O)c(c1cccc(c1)N(C)C)n(c(=O)c2)C
InChI InChI=1S/C21H19ClN4O2/c1-24(2)14-8-6-7-13(11-14)20-19-16(12-18(27)25(20)3)23-26(21(19)28)17-10-5-4-9-15(17)22/h4-12,23H,1-3H3
InChI Key RGYQPQARIQKJKH-UHFFFAOYSA-N
No information available.
Summary of Clinical Use Click here for help
GKT137831 has completed Phase 2 clinical evaluation in patients with diabetic nephropathy (NCT02010242). However, despite being safe and well tolerated, and showing statistically significant reductions in liver enzyme and inflammatory marker levels, this study's primary end point (reduction in albuminuria) was not met (unpublished results- see Genkyotex's webpage for GKT831). A further Phase 2 trial in primary biliary cirrhosis patients is underway (NCT03226067).
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT02010242 Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria Phase 2 Interventional Genkyotex Innovation SAS
NCT03226067 Study to Assess Safety and Efficacy of GKT137831 in Patients With Primary Biliary Cholangitis Receiving Ursodeoxycholic Acid. Phase 2 Interventional Genkyotex SA